Patent · US Active

Anti-IL-23 antibodies, compositions, methods and uses

US7807414B2 · kind B2 · utility

29Cited by
14References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 13, 2009
Grant dateOct 5, 2010
Priority date
Expiry dateApr 1, 2029

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An anti-IL-23p19 antibody, including isolated nucleic acids that encode at least one anti-IL-23p19 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.